Chu Saint-Etienne
Saint-Etienne, France
NCT Number: NCT04117308
Prospective mono-centric randomized open-label study (randomization 1: 1, 2 groups) comparing a group of patients who received conventional information to a group of patients who had been sensitized to a fetal active movement count technique.
The study will take place at the University Hospital Center of Saint-Etienne in the gynecology-obstetrics department.
An information brochure on the study will be handed over at the end of the term consultation to 41+0 weeks of gestation. After collecting the consent of the patient, the distribution between the two groups will be done by randomization. Thus, for the fetal active movement count group, fetal active movement count education will be proposed during the term consultation with the submission of an information brochure. The "control" group will also receive a simple information pamphlet with, in writing, what patients currently receive orally: definition of active fetal movements, and the need to consult if the patient perceives less movements of her fetus .The principal objective is to compare perinatal morbidity in relation with the sensation of decrease active fetal movements in case of late pregnancy, according to the fact if the patients use or not the AFM's count.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Saint-Etienne, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The team delivers to each patient a unique and standardized information brochure including a definition of fetal active movements, and the need to consult if the patient perceives less the movements of her fetus.
Delayed single and standardized explanatory card on fetal movements (definition, interests of their follow-up, technique of movements on fetuses, table to fill during the follow-up noting the number of active movements physical feelings at 3 times of the day, managing the decrease in the number of active fetal movements).
Time frame: At the delivery.
The primary outcome will be the presence of more than 2 criteria of a composite perinatal morbidity score:
Time frame: At the delivery.
Number of consultations with the sensation of decrease active fetal movements.
Time frame: At the delivery.
Consultation's delay in relation with the sensation of decrease active fetal movements (classified on <12 hours or >12hours).
Time frame: At the delivery.
Ranking of consultations in 'justified' or 'not justified' is depending on the result of the complementary examinations practiced (Ultrasound with Manning score, kleihauer test). A consultation for reduction of fetal active movements is considered justified if presence of abnormal fetal heart rate and / or Manning score less than 8/8 and / or positive kleihauer test.
Time frame: At the delivery.
Spontaneous or induction of labor, and explications for induction.
Time frame: At the delivery.
Caesarean, spontaneous outcome, assisted vaginal outcome.
Centre Hospitalier Universitaire de Saint Etienne
Other
Analysis of the Use of the Fetal Movement Counting for Prolonged Pregnancy: Prospective Randomized Study.
Acronym: COMPTAMAF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02932319
Female Urogenital Diseases and Pregnancy Complications, Induction of Labour
Caen, France
View Trial DetailsNCT02907060
Female Urogenital Diseases and Pregnancy Complications, Pregnancy Complications
Brest, France
View Trial DetailsNCT00930618
Female Urogenital Diseases and Pregnancy Complications, Nulliparity
Paris, France
View Trial DetailsNCT05840471
Abruptio Placentae, Death
Erbil, Kurdistan Region, Iraq
View Trial Details